| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| B-Lymphocytes | 45 | 2018 | 727 | 3.060 |
Why?
|
| Antibodies, Antinuclear | 27 | 2014 | 94 | 2.950 |
Why?
|
| Immunoglobulin Variable Region | 42 | 2018 | 87 | 2.550 |
Why?
|
| Immunoglobulin kappa-Chains | 33 | 2011 | 60 | 1.770 |
Why?
|
| Immunoglobulin Light Chains | 28 | 2014 | 66 | 1.670 |
Why?
|
| Immunoglobulin Heavy Chains | 40 | 2014 | 107 | 1.660 |
Why?
|
| Receptors, Antigen, B-Cell | 13 | 2012 | 106 | 1.630 |
Why?
|
| Genes, Immunoglobulin | 19 | 2012 | 62 | 1.610 |
Why?
|
| Autoantibodies | 16 | 2018 | 286 | 1.430 |
Why?
|
| Autoimmunity | 9 | 2011 | 195 | 1.380 |
Why?
|
| DNA | 28 | 2014 | 1274 | 1.240 |
Why?
|
| Immune Tolerance | 14 | 2022 | 386 | 1.060 |
Why?
|
| Lupus Erythematosus, Systemic | 9 | 2018 | 244 | 1.040 |
Why?
|
| Gene Rearrangement, B-Lymphocyte, Light Chain | 10 | 2008 | 15 | 1.030 |
Why?
|
| Gene Rearrangement, B-Lymphocyte | 11 | 2011 | 29 | 1.000 |
Why?
|
| Mice, Transgenic | 31 | 2019 | 1606 | 0.900 |
Why?
|
| Hybridomas | 29 | 2013 | 61 | 0.830 |
Why?
|
| Base Sequence | 41 | 2013 | 2222 | 0.790 |
Why?
|
| Mice | 100 | 2019 | 12718 | 0.780 |
Why?
|
| Microscopy, Electron | 1 | 2024 | 435 | 0.770 |
Why?
|
| Molecular Sequence Data | 36 | 2014 | 2894 | 0.750 |
Why?
|
| Complementarity Determining Regions | 4 | 2014 | 26 | 0.720 |
Why?
|
| Imaging, Three-Dimensional | 2 | 2024 | 630 | 0.680 |
Why?
|
| Immunoglobulin Class Switching | 3 | 2018 | 38 | 0.680 |
Why?
|
| Software | 2 | 2024 | 693 | 0.680 |
Why?
|
| Amino Acid Sequence | 40 | 2014 | 2003 | 0.640 |
Why?
|
| Hemagglutinins, Viral | 6 | 2008 | 38 | 0.630 |
Why?
|
| Autoantigens | 10 | 2018 | 145 | 0.620 |
Why?
|
| B-Lymphocyte Subsets | 4 | 2011 | 37 | 0.600 |
Why?
|
| Animals | 108 | 2019 | 28950 | 0.590 |
Why?
|
| Mice, Inbred BALB C | 30 | 2011 | 1110 | 0.580 |
Why?
|
| Binding Sites, Antibody | 18 | 2006 | 47 | 0.510 |
Why?
|
| Epitopes | 11 | 2018 | 259 | 0.500 |
Why?
|
| Antibody Specificity | 17 | 2014 | 125 | 0.490 |
Why?
|
| Immunoglobulin M | 10 | 2013 | 153 | 0.470 |
Why?
|
| Rheumatoid Factor | 10 | 1997 | 26 | 0.460 |
Why?
|
| Antibodies, Viral | 5 | 2008 | 339 | 0.460 |
Why?
|
| Antibodies, Monoclonal | 13 | 2008 | 1417 | 0.420 |
Why?
|
| Gene Rearrangement, B-Lymphocyte, Heavy Chain | 4 | 2003 | 16 | 0.420 |
Why?
|
| Models, Immunological | 7 | 2005 | 86 | 0.400 |
Why?
|
| Image Processing, Computer-Assisted | 3 | 2024 | 1303 | 0.390 |
Why?
|
| Immunoglobulin G | 11 | 2003 | 480 | 0.380 |
Why?
|
| Somatic Hypermutation, Immunoglobulin | 2 | 2011 | 20 | 0.360 |
Why?
|
| Mutation | 17 | 2015 | 4408 | 0.360 |
Why?
|
| Autoimmune Diseases | 9 | 2004 | 260 | 0.360 |
Why?
|
| Antibody Formation | 4 | 2007 | 172 | 0.340 |
Why?
|
| DNA, Single-Stranded | 5 | 1999 | 95 | 0.340 |
Why?
|
| RNA Editing | 3 | 2006 | 47 | 0.330 |
Why?
|
| Immunoglobulin lambda-Chains | 9 | 2004 | 19 | 0.330 |
Why?
|
| Antibody Diversity | 11 | 2007 | 18 | 0.320 |
Why?
|
| Recombination, Genetic | 17 | 2002 | 424 | 0.280 |
Why?
|
| Spleen | 7 | 2006 | 376 | 0.280 |
Why?
|
| Self Tolerance | 5 | 2014 | 26 | 0.270 |
Why?
|
| Precursor Cells, B-Lymphoid | 2 | 2022 | 27 | 0.260 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 1 | 2008 | 116 | 0.260 |
Why?
|
| Mice, Inbred MRL lpr | 6 | 2011 | 37 | 0.260 |
Why?
|
| Phosphatidylserines | 3 | 2008 | 21 | 0.250 |
Why?
|
| Immunoglobulin Idiotypes | 4 | 1992 | 11 | 0.250 |
Why?
|
| Apoptosis | 5 | 2022 | 1752 | 0.240 |
Why?
|
| Graft vs Host Reaction | 1 | 2006 | 14 | 0.240 |
Why?
|
| CDX2 Transcription Factor | 1 | 2026 | 8 | 0.240 |
Why?
|
| Antibodies, Antiphospholipid | 2 | 2003 | 10 | 0.240 |
Why?
|
| Immunologic Memory | 5 | 2018 | 188 | 0.230 |
Why?
|
| Sequence Homology, Amino Acid | 6 | 2014 | 403 | 0.230 |
Why?
|
| Alleles | 13 | 2006 | 1161 | 0.220 |
Why?
|
| Genome, Viral | 1 | 2005 | 83 | 0.220 |
Why?
|
| Bone Marrow | 2 | 2023 | 421 | 0.220 |
Why?
|
| Epitopes, T-Lymphocyte | 1 | 2005 | 99 | 0.210 |
Why?
|
| Rectal Neoplasms | 1 | 2026 | 138 | 0.210 |
Why?
|
| Data Collection | 1 | 2006 | 375 | 0.210 |
Why?
|
| Microscopy, Fluorescence | 1 | 2006 | 435 | 0.210 |
Why?
|
| Gene Rearrangement | 4 | 2006 | 175 | 0.210 |
Why?
|
| Spatial Analysis | 1 | 2024 | 14 | 0.210 |
Why?
|
| Myeloma Proteins | 20 | 1981 | 36 | 0.210 |
Why?
|
| Immunoglobulin Joining Region | 3 | 2000 | 8 | 0.200 |
Why?
|
| Influenza A virus | 3 | 1991 | 177 | 0.200 |
Why?
|
| Cell Nucleus | 4 | 2023 | 615 | 0.200 |
Why?
|
| Genes | 15 | 1986 | 256 | 0.200 |
Why?
|
| Organelles | 1 | 2024 | 55 | 0.200 |
Why?
|
| Cell Differentiation | 6 | 2007 | 1647 | 0.200 |
Why?
|
| Flow Cytometry | 7 | 2012 | 721 | 0.200 |
Why?
|
| Models, Molecular | 9 | 2013 | 1392 | 0.190 |
Why?
|
| Phenotype | 2 | 2012 | 2653 | 0.190 |
Why?
|
| Glycosaminoglycans | 2 | 2013 | 31 | 0.180 |
Why?
|
| Hematology | 1 | 2023 | 37 | 0.180 |
Why?
|
| Fluorescent Antibody Technique | 5 | 2026 | 310 | 0.180 |
Why?
|
| Blotting, Southern | 8 | 1994 | 107 | 0.170 |
Why?
|
| Humans | 33 | 2026 | 98223 | 0.170 |
Why?
|
| Isoantigens | 1 | 2002 | 74 | 0.170 |
Why?
|
| Golgi Apparatus | 2 | 2013 | 111 | 0.170 |
Why?
|
| Sequence Alignment | 4 | 2006 | 353 | 0.170 |
Why?
|
| snRNP Core Proteins | 2 | 2018 | 9 | 0.160 |
Why?
|
| Mutagenesis, Site-Directed | 6 | 2004 | 273 | 0.160 |
Why?
|
| Transgenes | 5 | 2007 | 173 | 0.160 |
Why?
|
| Antibodies, Anti-Idiotypic | 3 | 1990 | 45 | 0.160 |
Why?
|
| Antibody Affinity | 3 | 2014 | 38 | 0.160 |
Why?
|
| Algorithms | 4 | 2023 | 2001 | 0.160 |
Why?
|
| Genome, Human | 1 | 2005 | 833 | 0.160 |
Why?
|
| Mice, Inbred Strains | 11 | 2002 | 281 | 0.150 |
Why?
|
| Retinal Rod Photoreceptor Cells | 1 | 2019 | 11 | 0.150 |
Why?
|
| Plasmacytoma | 10 | 1987 | 26 | 0.150 |
Why?
|
| Genetic Linkage | 6 | 1989 | 613 | 0.150 |
Why?
|
| Polymerase Chain Reaction | 5 | 2016 | 894 | 0.150 |
Why?
|
| Contrast Sensitivity | 1 | 2019 | 72 | 0.150 |
Why?
|
| Immunoglobulin Fragments | 7 | 2009 | 23 | 0.140 |
Why?
|
| DNA-Binding Proteins | 3 | 2002 | 1261 | 0.140 |
Why?
|
| Motion Perception | 1 | 2019 | 104 | 0.140 |
Why?
|
| Cell Line | 7 | 2011 | 2482 | 0.140 |
Why?
|
| Mice, Inbred C57BL | 11 | 2019 | 3612 | 0.130 |
Why?
|
| DNA Repair Enzymes | 1 | 1998 | 65 | 0.130 |
Why?
|
| Mice, Mutant Strains | 8 | 2002 | 217 | 0.130 |
Why?
|
| Adenosine Triphosphatases | 1 | 1998 | 141 | 0.130 |
Why?
|
| Genetic Markers | 1 | 2018 | 471 | 0.130 |
Why?
|
| Disease Susceptibility | 1 | 2018 | 225 | 0.130 |
Why?
|
| Central Tolerance | 1 | 2016 | 8 | 0.120 |
Why?
|
| Biomarkers, Tumor | 1 | 2026 | 1770 | 0.120 |
Why?
|
| Protein Conformation | 4 | 2013 | 927 | 0.120 |
Why?
|
| Gene Expression Regulation | 7 | 2016 | 2020 | 0.120 |
Why?
|
| Pericytes | 1 | 2016 | 14 | 0.120 |
Why?
|
| Models, Genetic | 5 | 2005 | 1006 | 0.120 |
Why?
|
| Lymphoma | 2 | 1989 | 254 | 0.120 |
Why?
|
| Antigen-Presenting Cells | 1 | 2016 | 146 | 0.120 |
Why?
|
| DNA Repair | 1 | 1998 | 363 | 0.120 |
Why?
|
| Coculture Techniques | 1 | 2016 | 175 | 0.110 |
Why?
|
| RNA-Binding Protein FUS | 1 | 2015 | 9 | 0.110 |
Why?
|
| Membrane Proteins | 1 | 2022 | 1288 | 0.110 |
Why?
|
| T-Lymphocytes | 2 | 2016 | 1333 | 0.110 |
Why?
|
| Ribonucleoproteins, Small Nuclear | 1 | 1994 | 20 | 0.110 |
Why?
|
| Cell Communication | 1 | 2016 | 223 | 0.110 |
Why?
|
| Sumoylation | 1 | 2014 | 19 | 0.110 |
Why?
|
| Paraproteinemias | 1 | 2014 | 19 | 0.110 |
Why?
|
| Microscopy | 1 | 2015 | 92 | 0.110 |
Why?
|
| HSP90 Heat-Shock Proteins | 1 | 2014 | 45 | 0.110 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 5 | 2012 | 373 | 0.110 |
Why?
|
| Amyotrophic Lateral Sclerosis | 1 | 2015 | 155 | 0.100 |
Why?
|
| Clonal Deletion | 1 | 1994 | 24 | 0.100 |
Why?
|
| Proteins | 2 | 1998 | 803 | 0.100 |
Why?
|
| DNA Primers | 3 | 2004 | 530 | 0.100 |
Why?
|
| Wound Healing | 1 | 2016 | 384 | 0.100 |
Why?
|
| Dextrans | 6 | 1980 | 77 | 0.090 |
Why?
|
| Gene Expression | 3 | 2012 | 1321 | 0.090 |
Why?
|
| Endothelial Cells | 1 | 2016 | 502 | 0.090 |
Why?
|
| Receptors, Immunologic | 2 | 2007 | 143 | 0.090 |
Why?
|
| Bone Marrow Cells | 4 | 2023 | 269 | 0.090 |
Why?
|
| Receptors, Cell Surface | 1 | 2014 | 291 | 0.090 |
Why?
|
| Immunization, Passive | 1 | 2011 | 69 | 0.090 |
Why?
|
| Immune Complex Diseases | 1 | 2011 | 19 | 0.090 |
Why?
|
| HIV Antibodies | 1 | 2011 | 40 | 0.090 |
Why?
|
| Restriction Mapping | 4 | 1993 | 119 | 0.090 |
Why?
|
| Lymphocyte Activation | 6 | 2016 | 822 | 0.080 |
Why?
|
| Mice, Inbred A | 1 | 2011 | 21 | 0.080 |
Why?
|
| Case-Control Studies | 2 | 2014 | 2002 | 0.080 |
Why?
|
| Antigen-Antibody Complex | 1 | 2011 | 89 | 0.080 |
Why?
|
| Cross Reactions | 5 | 2004 | 116 | 0.080 |
Why?
|
| Lymphopenia | 1 | 2011 | 31 | 0.080 |
Why?
|
| Translocation, Genetic | 3 | 1987 | 245 | 0.080 |
Why?
|
| Models, Biological | 2 | 2016 | 1805 | 0.080 |
Why?
|
| Mice, Knockout | 2 | 2011 | 2209 | 0.080 |
Why?
|
| Genes, Switch | 1 | 1990 | 7 | 0.080 |
Why?
|
| Cloning, Molecular | 5 | 1994 | 582 | 0.080 |
Why?
|
| Aging | 2 | 2015 | 770 | 0.080 |
Why?
|
| Genes, Regulator | 1 | 1990 | 60 | 0.080 |
Why?
|
| Antibodies, Neutralizing | 1 | 2011 | 175 | 0.080 |
Why?
|
| Orthomyxoviridae | 1 | 1990 | 46 | 0.080 |
Why?
|
| Immunoglobulin Isotypes | 3 | 2002 | 33 | 0.080 |
Why?
|
| Graft vs Host Disease | 2 | 2003 | 379 | 0.080 |
Why?
|
| Female | 14 | 2026 | 51685 | 0.080 |
Why?
|
| Genetic Loci | 1 | 2011 | 263 | 0.080 |
Why?
|
| Immunoglobulins | 5 | 1982 | 124 | 0.070 |
Why?
|
| Computer Simulation | 4 | 2019 | 1147 | 0.070 |
Why?
|
| Indoles | 2 | 2012 | 334 | 0.070 |
Why?
|
| Multigene Family | 1 | 1989 | 204 | 0.070 |
Why?
|
| Antibodies | 4 | 1980 | 349 | 0.060 |
Why?
|
| Immunoglobulin Allotypes | 3 | 2003 | 5 | 0.060 |
Why?
|
| Clone Cells | 4 | 1998 | 221 | 0.060 |
Why?
|
| Immunoglobulin Subunits | 1 | 2006 | 2 | 0.060 |
Why?
|
| Immune System | 1 | 2007 | 106 | 0.060 |
Why?
|
| Cell Membrane | 1 | 2009 | 675 | 0.060 |
Why?
|
| Lymphocyte Count | 1 | 2006 | 99 | 0.060 |
Why?
|
| Chronic Disease | 2 | 2006 | 988 | 0.060 |
Why?
|
| Histocompatibility Antigens | 1 | 2005 | 38 | 0.060 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2026 | 110 | 0.060 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 1 | 2005 | 117 | 0.060 |
Why?
|
| Antigens, Viral | 1 | 2005 | 123 | 0.050 |
Why?
|
| Mice, Inbred NZB | 7 | 1982 | 13 | 0.050 |
Why?
|
| Lipopolysaccharides | 4 | 2006 | 313 | 0.050 |
Why?
|
| Transcription, Genetic | 4 | 1991 | 1133 | 0.050 |
Why?
|
| United States | 1 | 2018 | 8252 | 0.050 |
Why?
|
| Immunoglobulin D | 1 | 2004 | 6 | 0.050 |
Why?
|
| Immunomagnetic Separation | 1 | 2004 | 8 | 0.050 |
Why?
|
| Receptors, Interleukin-2 | 1 | 2004 | 68 | 0.050 |
Why?
|
| Arginine | 2 | 1995 | 143 | 0.050 |
Why?
|
| Histological Techniques | 1 | 2023 | 33 | 0.050 |
Why?
|
| Quantitative Trait Loci | 1 | 2008 | 665 | 0.050 |
Why?
|
| Monte Carlo Method | 2 | 2009 | 194 | 0.050 |
Why?
|
| Species Specificity | 6 | 1990 | 690 | 0.050 |
Why?
|
| Animals, Congenic | 1 | 2003 | 1 | 0.050 |
Why?
|
| Peptides | 2 | 2005 | 670 | 0.050 |
Why?
|
| Bone Marrow Examination | 1 | 2023 | 40 | 0.050 |
Why?
|
| Static Electricity | 1 | 2003 | 101 | 0.050 |
Why?
|
| Forkhead Box Protein O1 | 1 | 2022 | 30 | 0.050 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2022 | 35 | 0.050 |
Why?
|
| Crosses, Genetic | 6 | 2012 | 165 | 0.050 |
Why?
|
| Workflow | 1 | 2023 | 86 | 0.050 |
Why?
|
| RNA, Messenger | 5 | 1991 | 2068 | 0.050 |
Why?
|
| Visual Perception | 1 | 2006 | 341 | 0.040 |
Why?
|
| Isoelectric Point | 1 | 2001 | 12 | 0.040 |
Why?
|
| Biopsy | 1 | 2026 | 1224 | 0.040 |
Why?
|
| HIV Infections | 1 | 2011 | 1018 | 0.040 |
Why?
|
| Lysosomes | 1 | 2022 | 126 | 0.040 |
Why?
|
| Microscopy, Confocal | 2 | 2013 | 285 | 0.040 |
Why?
|
| Codon | 1 | 2001 | 116 | 0.040 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2022 | 152 | 0.040 |
Why?
|
| Transfection | 3 | 1994 | 883 | 0.040 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2022 | 188 | 0.040 |
Why?
|
| Polymorphism, Genetic | 1 | 1985 | 832 | 0.040 |
Why?
|
| Antigens, CD | 1 | 2002 | 484 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2022 | 370 | 0.040 |
Why?
|
| Amino Acid Substitution | 1 | 2001 | 334 | 0.040 |
Why?
|
| Immunophenotyping | 3 | 2007 | 227 | 0.040 |
Why?
|
| Glycoproteins | 1 | 2001 | 221 | 0.040 |
Why?
|
| Chromatin | 1 | 2004 | 459 | 0.040 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2026 | 1395 | 0.040 |
Why?
|
| Mutation, Missense | 1 | 2001 | 302 | 0.040 |
Why?
|
| Retinal Bipolar Cells | 1 | 2019 | 5 | 0.040 |
Why?
|
| Haplotypes | 1 | 2002 | 657 | 0.040 |
Why?
|
| Rhodopsin | 1 | 2019 | 21 | 0.040 |
Why?
|
| Scattering, Radiation | 1 | 2019 | 122 | 0.040 |
Why?
|
| Reproducibility of Results | 1 | 2006 | 2789 | 0.040 |
Why?
|
| Cardiolipins | 2 | 1991 | 18 | 0.040 |
Why?
|
| Cell Line, Tumor | 1 | 2006 | 2894 | 0.040 |
Why?
|
| Immunoglobulin Switch Region | 2 | 1990 | 6 | 0.040 |
Why?
|
| Genes, Reporter | 1 | 2019 | 276 | 0.040 |
Why?
|
| Retinal Ganglion Cells | 1 | 2019 | 73 | 0.040 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2007 | 2569 | 0.040 |
Why?
|
| Light | 1 | 2019 | 289 | 0.030 |
Why?
|
| Protein Structure, Tertiary | 2 | 2015 | 731 | 0.030 |
Why?
|
| Liver | 3 | 1990 | 1230 | 0.030 |
Why?
|
| Models, Statistical | 1 | 2002 | 602 | 0.030 |
Why?
|
| Mismatch Repair Endonuclease PMS2 | 1 | 1998 | 25 | 0.030 |
Why?
|
| Sequence Homology, Nucleic Acid | 2 | 1989 | 157 | 0.030 |
Why?
|
| Male | 7 | 2026 | 47195 | 0.030 |
Why?
|
| Immunoglobulin J-Chains | 2 | 1987 | 10 | 0.030 |
Why?
|
| Thymocytes | 1 | 2016 | 33 | 0.030 |
Why?
|
| Clonal Anergy | 1 | 1996 | 32 | 0.030 |
Why?
|
| Chromosome Mapping | 6 | 1985 | 1063 | 0.030 |
Why?
|
| Granulation Tissue | 1 | 2016 | 15 | 0.030 |
Why?
|
| Neoplasms, Experimental | 6 | 1983 | 263 | 0.030 |
Why?
|
| Dermis | 1 | 2016 | 30 | 0.030 |
Why?
|
| Sequence Deletion | 1 | 1997 | 207 | 0.030 |
Why?
|
| Deoxyribonucleoproteins | 1 | 1995 | 2 | 0.030 |
Why?
|
| Cell Count | 1 | 2016 | 195 | 0.030 |
Why?
|
| Microvessels | 1 | 2016 | 70 | 0.030 |
Why?
|
| Antigens, Ly | 2 | 1986 | 37 | 0.030 |
Why?
|
| Protein Aggregates | 1 | 2015 | 28 | 0.030 |
Why?
|
| Prealbumin | 1 | 1975 | 47 | 0.030 |
Why?
|
| Prions | 1 | 2015 | 53 | 0.030 |
Why?
|
| Jurkat Cells | 2 | 2008 | 85 | 0.030 |
Why?
|
| Computer Graphics | 1 | 2015 | 99 | 0.030 |
Why?
|
| SUMO-1 Protein | 1 | 2014 | 15 | 0.030 |
Why?
|
| Serum Albumin | 1 | 1975 | 126 | 0.030 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2016 | 301 | 0.030 |
Why?
|
| Immunologic Techniques | 1 | 1994 | 25 | 0.030 |
Why?
|
| Middle Aged | 3 | 2026 | 29494 | 0.030 |
Why?
|
| Point Mutation | 1 | 1995 | 237 | 0.030 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 1997 | 452 | 0.030 |
Why?
|
| Genes, Dominant | 1 | 2014 | 112 | 0.030 |
Why?
|
| Cytoplasm | 1 | 2015 | 276 | 0.030 |
Why?
|
| Oligosaccharides | 2 | 1974 | 28 | 0.030 |
Why?
|
| Information Storage and Retrieval | 1 | 2015 | 129 | 0.030 |
Why?
|
| Mice, Inbred C3H | 3 | 1987 | 370 | 0.030 |
Why?
|
| Genotype | 3 | 2006 | 1891 | 0.030 |
Why?
|
| Immunoglobulin Constant Regions | 2 | 1985 | 11 | 0.030 |
Why?
|
| Haptens | 4 | 1979 | 9 | 0.030 |
Why?
|
| Recombinant Fusion Proteins | 1 | 1995 | 557 | 0.030 |
Why?
|
| Heterozygote | 1 | 2014 | 390 | 0.020 |
Why?
|
| Electrochemistry | 1 | 1993 | 60 | 0.020 |
Why?
|
| Conserved Sequence | 1 | 2014 | 209 | 0.020 |
Why?
|
| Luminescent Measurements | 1 | 2013 | 64 | 0.020 |
Why?
|
| Structure-Activity Relationship | 2 | 1993 | 426 | 0.020 |
Why?
|
| X-Ray Diffraction | 1 | 2013 | 131 | 0.020 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2016 | 506 | 0.020 |
Why?
|
| Immunoassay | 1 | 2013 | 102 | 0.020 |
Why?
|
| Aged | 2 | 2026 | 21824 | 0.020 |
Why?
|
| Pedigree | 1 | 2014 | 983 | 0.020 |
Why?
|
| Immunogenetics | 1 | 1972 | 8 | 0.020 |
Why?
|
| Clodronic Acid | 1 | 2012 | 9 | 0.020 |
Why?
|
| Ligands | 2 | 2009 | 490 | 0.020 |
Why?
|
| CD40 Ligand | 1 | 2012 | 79 | 0.020 |
Why?
|
| Liposomes | 1 | 2012 | 104 | 0.020 |
Why?
|
| Hemocyanins | 1 | 1991 | 7 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-bcr | 1 | 2011 | 8 | 0.020 |
Why?
|
| Blotting, Northern | 1 | 1991 | 239 | 0.020 |
Why?
|
| Rabbits | 2 | 1984 | 582 | 0.020 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2011 | 137 | 0.020 |
Why?
|
| Binding, Competitive | 3 | 1984 | 136 | 0.020 |
Why?
|
| Kinetics | 2 | 1994 | 1477 | 0.020 |
Why?
|
| Oligonucleotides | 1 | 1991 | 93 | 0.020 |
Why?
|
| Immunoblotting | 1 | 2011 | 273 | 0.020 |
Why?
|
| Viral Load | 1 | 2011 | 162 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2015 | 1097 | 0.020 |
Why?
|
| Multiple Myeloma | 2 | 1979 | 372 | 0.020 |
Why?
|
| Oligonucleotide Probes | 1 | 1990 | 36 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2011 | 779 | 0.020 |
Why?
|
| Mice, Inbred AKR | 3 | 1980 | 9 | 0.020 |
Why?
|
| Radioimmunoassay | 2 | 1984 | 139 | 0.020 |
Why?
|
| Embryonic and Fetal Development | 1 | 1989 | 66 | 0.020 |
Why?
|
| In Vitro Techniques | 1 | 1991 | 945 | 0.020 |
Why?
|
| src-Family Kinases | 1 | 2009 | 70 | 0.020 |
Why?
|
| Cell Line, Transformed | 1 | 1989 | 153 | 0.020 |
Why?
|
| Immunoglobulin A | 4 | 1979 | 94 | 0.020 |
Why?
|
| Models, Theoretical | 1 | 2011 | 509 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 1991 | 994 | 0.020 |
Why?
|
| Bone Marrow Transplantation | 2 | 2002 | 286 | 0.020 |
Why?
|
| Lymphocyte Subsets | 1 | 2008 | 71 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2012 | 1816 | 0.020 |
Why?
|
| Genes, Immunoglobulin Heavy Chain | 1 | 2007 | 9 | 0.020 |
Why?
|
| Antigens, Nuclear | 1 | 2007 | 29 | 0.020 |
Why?
|
| Computers | 1 | 2007 | 102 | 0.020 |
Why?
|
| Immunization, Secondary | 1 | 1987 | 42 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2009 | 1145 | 0.020 |
Why?
|
| Stem Cells | 1 | 1989 | 397 | 0.020 |
Why?
|
| Signal Transduction | 2 | 2009 | 3627 | 0.020 |
Why?
|
| Leukocyte Count | 1 | 1986 | 215 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 1987 | 1028 | 0.010 |
Why?
|
| Gene Rearrangement, beta-Chain T-Cell Antigen Receptor | 1 | 2005 | 16 | 0.010 |
Why?
|
| Gene Rearrangement, alpha-Chain T-Cell Antigen Receptor | 1 | 2005 | 9 | 0.010 |
Why?
|
| Stochastic Processes | 1 | 2005 | 77 | 0.010 |
Why?
|
| DNA Restriction Enzymes | 1 | 1985 | 76 | 0.010 |
Why?
|
| Hemagglutinin Glycoproteins, Influenza Virus | 1 | 1985 | 85 | 0.010 |
Why?
|
| Genetic Code | 3 | 1974 | 24 | 0.010 |
Why?
|
| Antigens | 2 | 2003 | 225 | 0.010 |
Why?
|
| Time Factors | 2 | 2007 | 5573 | 0.010 |
Why?
|
| Binding Sites | 3 | 1978 | 1159 | 0.010 |
Why?
|
| Cell Division | 1 | 2005 | 690 | 0.010 |
Why?
|
| Adult | 2 | 2014 | 29548 | 0.010 |
Why?
|
| Genetic Variation | 1 | 1970 | 1452 | 0.010 |
Why?
|
| Hybrid Cells | 2 | 1981 | 68 | 0.010 |
Why?
|
| Risk Factors | 1 | 2014 | 6269 | 0.010 |
Why?
|
| Chromosome Deletion | 2 | 1981 | 215 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 1 | 2006 | 914 | 0.010 |
Why?
|
| beta 2-Glycoprotein I | 1 | 2001 | 5 | 0.010 |
Why?
|
| Leukemia, Experimental | 1 | 1981 | 15 | 0.010 |
Why?
|
| Ascitic Fluid | 1 | 1981 | 36 | 0.010 |
Why?
|
| Young Adult | 1 | 2014 | 7556 | 0.010 |
Why?
|
| Nucleic Acid Precursors | 1 | 1980 | 2 | 0.010 |
Why?
|
| DNA, Recombinant | 1 | 1980 | 60 | 0.010 |
Why?
|
| RNA, Neoplasm | 1 | 1980 | 87 | 0.010 |
Why?
|
| H-2 Antigens | 1 | 1980 | 58 | 0.010 |
Why?
|
| Rats | 1 | 1985 | 4073 | 0.010 |
Why?
|
| Cytochrome c Group | 1 | 1997 | 82 | 0.010 |
Why?
|
| Entropy | 1 | 1997 | 40 | 0.010 |
Why?
|
| Dimerization | 1 | 1997 | 149 | 0.010 |
Why?
|
| Erythrocytes | 2 | 1982 | 242 | 0.010 |
Why?
|
| Immunochemistry | 2 | 1974 | 18 | 0.010 |
Why?
|
| Radiation Chimera | 1 | 1996 | 22 | 0.010 |
Why?
|
| Biological Evolution | 1 | 1985 | 1077 | 0.010 |
Why?
|
| Adoptive Transfer | 1 | 1996 | 174 | 0.010 |
Why?
|
| Arthritis, Rheumatoid | 1 | 1997 | 190 | 0.010 |
Why?
|
| Isoantibodies | 1 | 1977 | 135 | 0.010 |
Why?
|
| Crossing Over, Genetic | 1 | 1975 | 34 | 0.010 |
Why?
|
| Mice, Inbred DBA | 1 | 1975 | 146 | 0.010 |
Why?
|
| Autoanalysis | 1 | 1973 | 6 | 0.010 |
Why?
|
| Thermolysin | 1 | 1973 | 9 | 0.010 |
Why?
|
| Chromatography | 1 | 1973 | 25 | 0.010 |
Why?
|
| Chymotrypsin | 1 | 1973 | 29 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 1994 | 380 | 0.010 |
Why?
|
| Electrophoresis | 1 | 1973 | 47 | 0.010 |
Why?
|
| Trypsin | 1 | 1973 | 92 | 0.010 |
Why?
|
| Iodine Radioisotopes | 1 | 1974 | 145 | 0.010 |
Why?
|
| Hydrolysis | 1 | 1973 | 145 | 0.010 |
Why?
|
| Iodine Isotopes | 1 | 1973 | 18 | 0.010 |
Why?
|
| Antigen-Antibody Reactions | 1 | 1973 | 18 | 0.010 |
Why?
|
| Disaccharides | 1 | 1973 | 24 | 0.010 |
Why?
|
| Maltose | 1 | 1973 | 33 | 0.010 |
Why?
|
| Immune Sera | 1 | 1972 | 48 | 0.010 |
Why?
|
| Sheep | 1 | 1972 | 204 | 0.010 |
Why?
|
| Cryoglobulins | 1 | 1992 | 4 | 0.010 |
Why?
|
| Immunization | 1 | 1972 | 154 | 0.010 |
Why?
|
| Polysaccharides | 1 | 1972 | 99 | 0.010 |
Why?
|
| Glomerulonephritis | 1 | 1992 | 80 | 0.010 |
Why?
|
| Syndrome | 1 | 1992 | 441 | 0.010 |
Why?
|
| Molecular Biology | 1 | 1970 | 83 | 0.000 |
Why?
|
| Skin Diseases | 1 | 1992 | 177 | 0.000 |
Why?
|
| Disease Models, Animal | 1 | 1996 | 2575 | 0.000 |
Why?
|
| Nucleic Acid Hybridization | 2 | 1978 | 195 | 0.000 |
Why?
|
| Selection, Genetic | 1 | 1970 | 572 | 0.000 |
Why?
|
| Animals, Wild | 1 | 1982 | 53 | 0.000 |
Why?
|
| Protein Binding | 2 | 1978 | 1557 | 0.000 |
Why?
|
| Gene Amplification | 1 | 1982 | 142 | 0.000 |
Why?
|
| Antilymphocyte Serum | 1 | 1982 | 68 | 0.000 |
Why?
|
| Coliphages | 1 | 1979 | 38 | 0.000 |
Why?
|
| Extracellular Space | 1 | 1979 | 84 | 0.000 |
Why?
|
| Immunoglobulin gamma-Chains | 1 | 1978 | 3 | 0.000 |
Why?
|
| Immunoglobulin alpha-Chains | 1 | 1978 | 3 | 0.000 |
Why?
|
| Immunoglobulin mu-Chains | 1 | 1978 | 6 | 0.000 |
Why?
|
| Phosphorylcholine | 1 | 1978 | 22 | 0.000 |
Why?
|
| Nitrobenzenes | 1 | 1975 | 12 | 0.000 |
Why?
|
| Inulin | 1 | 1972 | 17 | 0.000 |
Why?
|
| Precipitin Tests | 1 | 1972 | 101 | 0.000 |
Why?
|
| Fructose | 1 | 1972 | 38 | 0.000 |
Why?
|
| Glucose | 1 | 1972 | 704 | 0.000 |
Why?
|